Tweets
If you see a patient with fatigue and arthralgias please screen for depression before you order a battery of serologies. Pain is a common feature of depression #MedEd https://t.co/0FCugZRbgI
Yousaf Ali MD @yousafali_md ( View Tweet )
4 years 9 months ago
ICYMI:New Download Available!
FDA EUA for Baricitinib in COVID
https://t.co/yTQLb7DDvR https://t.co/p6NPCXa0Fn
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow
https://t.co/riyAnrRHhX https://t.co/XIJIMdvQ2g
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Biologic Use and the Risk of Serious Infection in Psoriasis Patients
https://t.co/zU8ZaYjGyf https://t.co/jpAITJOFpi
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Rheumatologists are setting cardiology straight about hydroxychloroquine and chloroquine. This, and a special recognition of parent-child rheumatologists, along with the news and articles from this week on RheumNow.
https://t.co/zuowQS3pTK https://t.co/eToS9zjqss
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
BEAT-LUPUS: Sequential Belimumab After Rituximab in SLE
https://t.co/4hUBRnhdhl https://t.co/xj900Vd8qt
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Nationwide 2 yr F/U study, 11 centers, 300 pts with early (1.2 yrs) systemic sclerosis shows, despite most (2/3) on immunosuppressives, 71% progressed to diffuse SSc, 21% worsen Skin, 23% worse FVC & 6.6% died (cardiac, GI, ILD) https://t.co/UfagmX2S16
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
ACR Applauds Bipartisan Letter Urging Congressional Action to Avoid Looming “Medicare Cliff” https://t.co/KXNHRdubZk
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Nature has published a full read over of "Homing in on an oral link to inflammatory disease" how the microbiome may be a pathogenic link to diseases like RA. https://t.co/wwB9Eg9nsH
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Baricitinib long-term safety in #RA - 3770 pts (14744 PYs). Incid rates/100 pt-yrs:
- Serious infx 2.6
- H. Zoster 3
- MACE 0.5
- In pts ≥50yr w/ ≥1 CV risk MACE = 0.77 for 1st 2 yrs, then 0.6
- Cancer SIR 1.07 w/ low SMR 0.74
- DVT/PE risk 0.5 & 0.4 https://t.co/amdzvXSZb4 https://t.co/3Si98fL6Z9
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
MMWR reports those who have recv COVID-19 vaccine have lower risk non–COVID-19 mortality (vs unvaccinated). Adjusted rel risk of non–COVID-19 death for Pfizer-vaccine (2 doses RR 0.34), Moderna (0.31), Janssen (0.54). NO INCR MORTAL RISK IN VACCINATED https://t.co/X6X1w1aYoU
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
"ECG monitoring is not part of the current standard practice when HCQ or CQ is prescribed for...rheumatologic or dermatologic conditions."
-pub 10/26/21 ACR White Paper on Antimalarial Cardiac Toxicity https://t.co/uBqm5LBsob
TheDaoIndex @KDAO2011 ( View Tweet )
4 years 9 months ago
